NovaCell Holding Launches: A Global Powerhouse in AI-Driven Regenerative Longevity Solutions
Cannes, Dubai, Paris, Amsterdam, Shanghai – July 2025 – NovaGen Group and Celljevity are excited to announce the upcoming merger that will birth NovaCell Holding, a new global leader at the forefront of artificial intelligence and regenerative medicine. This strategic alliance combines cutting-edge AI diagnostic platforms, digital twin modeling, and premium longevity clinics with advanced regenerative therapies, forging a comprehensive approach to extending healthspan and revitalizing the human body.
Revolutionizing Health Through Innovation
Celljevity’s pioneering work in cellular and epigenetic rejuvenation, supported by over 100 peer-reviewed studies, enables therapies that reverse biological age by more than 10 years using a patient’s own cells. The therapies boast a strong safety profile, having been administered to over 1,000 patients globally, and have demonstrated notable results:
- 32% telomere extension
- 90% relief in autoimmune conditions
- Improvements in early-stage Alzheimer’s and Parkinson’s symptoms
By integrating Celljevity’s cellular rejuvenation platform with NovaGen’s AI diagnostics and digital twin technology, NovaCell offers personalized, end-to-end longevity solutions delivered through a network of luxury wellness clinics worldwide.
A New Standard in Personalized, Transformative Healthcare
Diederik van der Reijt, Group CEO and co-founder of Celljevity alongside Professor Yi Eve Sun, shared, “We’re creating a new standard for how individuals experience medicine proactive, predictive, personalized, and deeply transformative.”
A Seamless, Luxurious Wellness Experience
Clients of NovaCell Holding will benefit from:
- AI-driven multi-omics health profiling
- Digital twin simulations for precise treatment planning
- Proprietary, cell-based rejuvenation therapies
- Concierge clinics in iconic global cities featuring world-class clinicians and amenities
From preventive insights to regenerative interventions, NovaCell’s approach aims to deliver a seamless, luxurious, and highly effective health journey.
Empowering Longer, Healthier Lives Globally
With expansion plans across Europe, the Middle East, and North Africa, NovaCell Holding is committed to building:
- A global platform for regenerative longevity
- A robust clinical research network for continuous innovation
- A patient-centered model focused on empowerment, vitality, and quality of life
For more information, visit www.novagengroup.com and celljevity.life.
